Ignite Creation Date:
2024-05-05 @ 9:22 PM
Last Modification Date:
2024-10-26 @ 10:02 AM
Study NCT ID:
NCT00861861
Status:
COMPLETED
Last Update Posted:
2013-10-14
First Post:
2009-03-12
Brief Title:
Comparison of Pitavastatin With Atorvastatin in Increasing High Density Lipoprotein - Cholesterol HDL-C and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease CAD
Sponsor:
Kumamoto University
Organization:
Kumamoto University
Study Overview
Official Title:
Comparison of Pitavastatin With Atorvastatin in Increasing HDL-C and Adiponectin in Patients With Dyslipidemia and Coronary Artery Disease
Status:
COMPLETED
Status Verified Date:
2013-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
COMPACT-CAD
Brief Summary:
The purpose of this study is to compare the effects of pitavastatin and atorvastatin on adiponectin percentage change in patients with hypercholesteremia comorbid stable CAD
Detailed Description:
The efficiency of lipid lowering therapy was already proven by the clinical trials of statins According to these results the target value of LDL-C is recommended under 100mgdL in the Japan Atherosclerosis Society Guidelines However the efficiency of intensive therapy to lower LDL-C more than 100mgdL has not been proven yet
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None